サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1226920

欧州の水産養殖用ワクチンの2028年までの市場予測 - ワクチンタイプ別、種別、投与経路別の地域分析

Europe Aquaculture Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type of Vaccine, Species, and Route of Administration
出版日: | 発行: The Insight Partners | ページ情報: 英文 126 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
欧州の水産養殖用ワクチンの2028年までの市場予測 - ワクチンタイプ別、種別、投与経路別の地域分析
出版日: 2023年02月17日
発行: The Insight Partners
ページ情報: 英文 126 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の水産養殖用ワクチン市場は、2022年の9,858万米ドルから2028年には2億254万米ドルに成長すると予測されています。2022年から2028年までのCAGRは12.8%で成長すると推定されています。

水生動物由来食品への需要急増が欧州の水産養殖用ワクチン市場を牽引

オイル、キャビア、プロテインパウダー、肉などの水生動物由来の食品に対する需要の高まりは、農家が高い収益性を得るために養殖用のワクチン接種を行うことを奨励しています。消費者が動物性タンパク質の栄養価の高さを認識するようになっています。また、健康的で持続可能、かつ高品質な、薬剤をほとんど使用しない肉製品への要求も急速に高まっています。魚の定期的な摂取は、健康的な食生活の一部として広く奨励されています。魚は陸上動物の肉に比べてタンパク質含有量が高く、陸上動物よりも飼料転換率（FCR）が低く、魚からこの低い飼料率を利用してより多くのタンパク質を生産することができます。さらに、魚肉タンパク質は消化率が高く、動物性タンパク質に少ない必須アミノ酸を豊富に含んでいます。魚介類の摂取は、心臓病、炎症、関節炎のリスクを低下させることができます。魚の健康効果は、主に長鎖オメガ3（n-3）多価不飽和脂肪酸（PUFA）の存在に関連しています。さらに、魚のタンパク質は、生物活性ペプチドの豊富な供給源です。これらは、適切な濃度で摂取され、ヒトの体内で生物学的に利用可能であれば、多くのポジティブな健康上の利点を提供することができます。さらに、レニン-アンジオテンシン-アルドステロン系（RAAS）内の酵素の阻害による血圧のコントロール、骨の健康維持、炎症のコントロール（抗酸化ペプチド）、オピオイドペプチドと血小板活性化因子アセチル-ヒドロラーゼ阻害（PAF-AH）ペプチドの作用による精神衛生など、いくつかの生物活性による健康効果があります。このように、水産動物の健康的な飼育の必要性が高まっており、欧州の水産養殖用ワクチン市場を後押ししています。

欧州の水産養殖用ワクチン市場の概要

欧州の水産養殖用ワクチン市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。この地域は、水産養殖用ワクチン市場において大きな市場シェアを占めています。欧州の水産養殖用ワクチン市場は、水産養殖産業の著しい成長、水産動物由来の食品需要の急増、同地域の市場関係者による水産養殖用ワクチン開発のための研究開発活動の活発化などの要因により、予測期間中に大きな成長を遂げると予想されます。

英国は、欧州における主要な漁業・養殖国の一つです。OECD Review of Fisheries 2020では、2018年、英国は90万トンの魚を生産し、その価値は26億6,720万米ドルとなっています。この価値の50％は養殖から、50％は漁業からもたらされました。2008年から2018年の間に、生産量は17%改善し、その価値は25%増加しました。英国は、魚と魚介類の純輸入国です。2008年から2018年の間に、輸出は合計で18%増加しました。DNAワクチンは、より短い生産スケジュールで、コスト効率が高く、安全で、より効果的な予防接種を可能にする可能性があり、入手性を向上させます。DNAワクチンはすでに安全性と有効性が示されており、獣医療用としてすでに承認が下りています。しかし、これらは商業的な拡張性という点でいくつかの制約があり、その結果、普及は限定的でした。このように、養殖生産量の増加や市場プレイヤーの無機的な成長戦略の採用が、予測期間中の欧州の水産養殖用ワクチン市場の成長を促進するものと思われます。

欧州の水産養殖用ワクチン市場の収益と2028年までの予測（金額）

欧州の水産養殖用ワクチン市場のセグメンテーション

欧州の水産養殖用ワクチン市場は、ワクチンタイプ別、種別、投与経路別、国別に区分されます。

ワクチンタイプに基づき、欧州の水産養殖用ワクチン市場は、生ワクチンと不活化ワクチン、その他のワクチンにセグメント化されます。2022年には、不活化ワクチン分野が最大の市場シェアを占めています。

生物種に基づき、欧州の水産養殖用ワクチン市場は、ティラピア、トラウト、サーモン、エビ、その他に分けられます。2022年にはサーモン部門が最大のシェアを占めました。

投与経路に基づき、欧州の水産養殖用ワクチン市場は、注射用ワクチン、浸漬型ワクチン、経口ワクチンに区分されます。2022年には、注射用ワクチン市場が最大のシェアを占めています。

国別に見ると、欧州の水産養殖用ワクチン市場は、ドイツ、英国、フランス、イタリア、スペイン、ノルウェー、その他欧州に区分されます。2022年の水産養殖用ワクチン市場シェアはノルウェーが独占しています。

Microsynbiotix Ltd、HIPRA SA、Merck &Co Inc.、Zoetis Inc.、Phibro Animal Health Corp、Elanco Animal Health Inc.は、欧州の水産養殖用ワクチン市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 欧州の水産養殖用ワクチン市場-主要な要点

第3章 調査手法

  • カバレッジ
  • 2次調査
  • 1次調査

第4章 欧州の水産養殖用ワクチン市場-市場情勢

  • 欧州PEST分析
  • 専門家の見解

第5章 欧州の水産養殖用ワクチン市場-主要市場力学

  • 市場促進要因
    • 成長する水産養殖産業
    • 水生動物由来食品への需要の高まり
  • 市場抑制要因
    • ワクチン認可のための厳しい規制政策とワクチンコストの高さ
  • 今後の動向
    • 新規ワクチンの開発
  • 影響分析

第6章 水産養殖用ワクチン市場-欧州の分析

  • 欧州の水産養殖用ワクチン市場の収益と予測・分析

第7章 欧州の水産養殖用ワクチン市場の収益と2028年までの予測- ワクチンタイプ別

  • 欧州の水産養殖用ワクチン市場の収益シェア、ワクチンタイプ別、2021年・2028年（%）
  • 生ワクチン
  • 不活化ワクチン
  • その他のワクチン

第8章 欧州の水産養殖用ワクチン市場分析と2028年までの予測- 種別

  • 欧州の水産養殖用ワクチン市場、種別、2021年・2028年（%）
  • ティラピア
  • トラウト
  • サーモン
  • エビ
  • その他

第9章 欧州の水産養殖用ワクチン市場の収益と2028年までの予測- 投与経路別

  • 欧州の水産養殖用ワクチン市場の収益シェア、投与経路別、2021年・2028年（%）
  • 注射用ワクチン
  • 浸漬型ワクチン
  • 経口ワクチン

第10章 欧州の水産養殖用ワクチン市場の収益と2028年までの予測- 国別分析

    • 欧州
      • ドイツ
      • 英国
      • フランス
      • イタリア
      • スペイン
      • ノルウェー
      • その他欧州

第11章 水産養殖用ワクチン市場- 業界情勢

  • 水産養殖用ワクチン市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • HIPRA SA
  • Merck & Co Inc
  • Microsynbiotix Ltd
  • Zoetis Inc
  • Phibro Animal Health Corp
  • Elanco Animal Health Inc

第13章 付録

図表

List Of Tables

  • Table 1. Germany Aquaculture Vaccines Market, by Type of Vaccine - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. Germany Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. Germany Aquaculture Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. UK Aquaculture Vaccines Market, by Type of Vaccine - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. UK Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. UK Aquaculture Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. France Aquaculture Vaccines Market, by Type of Vaccine - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. France Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. France Aquaculture Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Italy Aquaculture Vaccines Market, by Type of Vaccine - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Italy Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Italy Aquaculture Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Spain Aquaculture Vaccines Market, by Type of Vaccine - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Spain Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Spain Aquaculture Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Norway Aquaculture Vaccines Market, by Type of Vaccine - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Norway Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Norway Aquaculture Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Rest of Europe Aquaculture Vaccines Market, by Type of Vaccine - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Italy Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Rest of Europe Aquaculture Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Recent Organic Growth Strategies in Aquaculture Vaccines Market
  • Table 23. Recent Inorganic Growth Strategies in the Aquaculture Vaccines Market
  • Table 24. Glossary of Terms

List Of Figures

  • Figure 1. Europe Aquaculture Vaccines Market Segmentation
  • Figure 2. Europe Aquaculture Vaccines Market, by Country
  • Figure 3. Europe Aquaculture Vaccines Market Overview
  • Figure 4. Inactivated Vaccine Segment Held Largest Share of Type Segment in Europe Aquaculture Vaccines Market
  • Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Europe: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. Europe Aquaculture Vaccines Market Impact Analysis of Drivers and Restraints
  • Figure 9. Europe Aquaculture Vaccines Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 10. Europe Aquaculture Vaccines Market Revenue Share, by Type of Vaccine 2021 & 2028 (%)
  • Figure 11. Live Vaccines: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Inactivated Vaccines: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Other Vaccines: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Europe Aquaculture Vaccines Market, by Species 2021 & 2028 (%)
  • Figure 15. Tilapia: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Trout: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Salmon: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Shrimps: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Others: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Europe Aquaculture Vaccines Market Revenue Share, by Route of Administration 2021 & 2028 (%)
  • Figure 21. Injection Vaccines: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Immersions Vaccines: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Oral Vaccines: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Europe: Aquaculture Vaccines Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 25. Europe: Aquaculture Vaccines Market, by Country, 2021 & 2028 (%)
  • Figure 26. Germany: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. UK: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. France: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Italy: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Spain: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Norway: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Rest of Europe: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Growth Strategies in Aquaculture Vaccines Market
目次
Product Code: BMIRE00028093

The Europe aquaculture vaccines market is expected to grow from US$ 98.58 million in 2022 to US$ 202.54 million by 2028. It is estimated to grow at a CAGR of 12.8% from 2022 to 2028.

Surging Demand for Aquatic Animal-Derived Food Products is Driving the Europe Aquaculture Vaccines Market

The growing demand for aquatic animal-derived food products such as oil, caviar, protein powders, and meat encourages farmers to use vaccinations for aquaculture to gain high profitability. Consumers are becoming aware of the nutritious value of animal protein. The demand for healthy, sustainable, and high-quality meat products with fewer or no drugs is also increasing rapidly. Regular fish consumption is widely promoted as a part of a healthy diet. Fishes have a high protein content compared to terrestrial animal meat and have a lower feed conversion rate (FCR) than land animals, and more protein can be produced using this lower feed rate from fish. Furthermore, fish protein is highly digestible and rich in essential amino acids that are low in animal-sourced protein. Fish and shellfish consumption can decrease the risk of heart disease, inflammation, and arthritis. The health benefits of fish are mainly linked to the presence of long-chain omega 3 (n -3) polyunsaturated fatty acids (PUFA). In addition, fish protein is a rich source of bioactive peptides. These can offer many positive health benefits if they are consumed in an appropriate concentration and bioavailable within the human body. Further, health benefits include the control of blood pressure through the inhibition of enzymes within the renin-angiotensin-aldosterone system (RAAS); maintenance of bone health; control of inflammation (antioxidant peptides), mental health through the action of opioid peptides and platelet-activating factor acetyl-hydrolase inhibitory (PAF-AH) peptides), and several other bioactivities. Thus, the need for healthy breeding of aquatic animals is increasing, propelling the Europe aquaculture vaccines market .

Europe Aquaculture Vaccines Market Overview

The Europe aquaculture vaccines market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the aquaculture vaccines market. The European aquaculture vaccines market is expected to witness significant growth during the forecast period due to factors such as the significant growth in aquaculture industry, surging demand for aquatic animal-derived food products, growing research and development activities for aquaculture vaccines development by market players in the region.

The UK is one of the major fisheries and aquaculture nations in Europe. The OECD Review of Fisheries 2020, In 2018, the UK produced 0.9 million tonnes of fish, with a value of US$ 2667.2 million. 50% of this value came from aquaculture and 50% from fisheries. Between 2008 and 2018, the quantity produced improved by 17%, while its value increased by 25%. The UK is a net importer of fish and fish products. Between 2008 and 2018, exports grew by a total of 18%. DNA vaccines have the potential to enable cost-efficient, safe, and more effective immunization with shorter production timelines, improving availability. DNA vaccines have already been shown to be safe and effective, with approvals already granted for veterinary use. However, these have shown some limitations in terms of commercial scalability, which resulted in limited widespread adoption. Thus, the increasing aquaculture production, and market players are adopting inorganic growth strategies are likely to foster the growth of the Europe aquaculture vaccines market during the forecast period.

Europe Aquaculture Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Europe Aquaculture Vaccines Market Segmentation

The Europe aquaculture vaccines market is segmented into type of vaccine, species, route of administration, and country.

Based on type of vaccine the Europe aquaculture vaccines market, is segmented into live vaccines, inactivated vaccines, other vaccines. The inactivated vaccines segment held the largest market share in in 2022.

Based on species, the Europe aquaculture vaccines market is divided into tilapia, trout, salmon, shrimps, and others. The salmon segment held the largest share of the market in 2022.

Based on route of administration the Europe aquaculture vaccines market, is segmented into injection vaccines, immersions vaccines, and oral vaccines. The injection vaccines segment held the largest share of the market in 2022.

Based on country, the Europe aquaculture vaccines market is segmented into the Germany, the UK, France, Italy, Spain, Norway, and the Rest of Europe. Norway dominated the aquaculture vaccines market share in 2022.

Microsynbiotix Ltd; HIPRA SA; Merck & Co Inc.; Zoetis Inc.; Phibro Animal Health Corp; and Elanco Animal Health Inc. are the leading companies operating in the Europe aquaculture vaccines market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe aquaculture vaccines market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe aquaculture vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the aquaculture vaccines market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Aquaculture Vaccines Market - by Type of Vaccine
    • 1.3.2 Europe Aquaculture Vaccines Market - by Species
    • 1.3.3 Europe Aquaculture Vaccines Market - by Route of Administration
    • 1.3.4 Europe Aquaculture Vaccines Market - by Country

2. Europe Aquaculture Vaccines Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Aquaculture Vaccines Market - Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis
  • 4.3 Expert's Opinion

5. Europe Aquaculture Vaccines Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Aquaculture Industry
    • 5.1.2 Surging Demand for Aquatic Animal-Derived Food Products
  • 5.2 Market Restraints
    • 5.2.1 Strict Regulatory Policies for Approval of Vaccines and High Cost of Vaccines
  • 5.3 Future Trends
    • 5.3.1 Development of Novel Vaccines
  • 5.4 Impact Analysis

6. Aquaculture Vaccines Market - Europe Analysis

  • 6.1 Europe Aquaculture Vaccines Market Revenue Forecast & Analysis

7. Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 - by Type of Vaccine

  • 7.1 Overview
  • 7.2 Europe Aquaculture Vaccines Market Revenue Share, by Type of Vaccine 2021 & 2028 (%)
  • 7.3 Live Vaccines
    • 7.3.1 Overview
    • 7.3.2 Live Vaccines: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Inactivated Vaccines
    • 7.4.1 Overview
    • 7.4.2 Inactivated Vaccines: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Other Vaccines
    • 7.5.1 Overview
    • 7.5.2 Other Vaccines: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Aquaculture Vaccines Market Analysis and Forecasts to 2028 - by Species

  • 8.1 Overview
  • 8.2 Europe Aquaculture Vaccines Market, by Species 2021 & 2028 (%)
  • 8.3 Tilapia
    • 8.3.1 Overview
    • 8.3.2 Tilapia: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Trout
    • 8.4.1 Overview
    • 8.4.2 Trout: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Salmon
    • 8.5.1 Overview
    • 8.5.2 Salmon: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Shrimps
    • 8.7.1 Overview
    • 8.7.2 Shrimps: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 - by Route of Administration

  • 9.1 Overview
  • 9.2 Europe Aquaculture Vaccines Market Revenue Share, by Route of Administration 2021 & 2028 (%)
  • 9.3 Injection Vaccines
    • 9.3.1 Overview
    • 9.3.2 Injection Vaccines: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Immersions Vaccines
    • 9.4.1 Overview
    • 9.4.2 Immersions Vaccines: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Oral Vaccines
    • 9.5.1 Overview
    • 9.5.2 Oral Vaccines: Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

10. Europe Aquaculture Vaccines Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Overview
    • 10.1.1 Europe: Aquaculture Vaccines Market, by Country, 2021 & 2028 (%)
      • 10.1.1.1 Germany: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 Germany: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 Germany: Aquaculture Vaccines Market, by Type of Vaccine, 2019-2028 (US$ Million)
        • 10.1.1.1.4 Germany: Aquaculture Vaccines Market, by Species, 2019-2028 (US$ Million)
        • 10.1.1.1.5 Germany: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
      • 10.1.1.2 UK: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 UK: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 UK: Aquaculture Vaccines Market, by Type of Vaccine, 2019-2028 (US$ Million)
        • 10.1.1.2.4 UK: Aquaculture Vaccines Market, by Species, 2019-2028 (US$ Million)
        • 10.1.1.2.5 UK: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
      • 10.1.1.3 France: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 France: Aquaculture Vaccines Market, by Type of Vaccine, 2019-2028 (US$ Million)
        • 10.1.1.3.4 France: Aquaculture Vaccines Market, by Species, 2019-2028 (US$ Million)
        • 10.1.1.3.5 France: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
      • 10.1.1.4 Italy: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.3 Italy: Aquaculture Vaccines Market, by Type of Vaccine, 2019-2028 (US$ Million)
        • 10.1.1.4.4 Italy: Aquaculture Vaccines Market, by Species, 2019-2028 (US$ Million)
        • 10.1.1.4.5 Italy: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
      • 10.1.1.5 Spain: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.3 Spain: Aquaculture Vaccines Market, by Type of Vaccine, 2019-2028 (US$ Million)
        • 10.1.1.5.4 Spain: Aquaculture Vaccines Market, by Species, 2019-2028 (US$ Million)
        • 10.1.1.5.5 Spain: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
      • 10.1.1.6 Norway: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Norway: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.3 Norway: Aquaculture Vaccines Market, by Type of Vaccine, 2019-2028 (US$ Million)
        • 10.1.1.6.4 Norway: Aquaculture Vaccines Market, by Species, 2019-2028 (US$ Million)
        • 10.1.1.6.5 Norway: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
      • 10.1.1.7 Rest of Europe: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.7.1 Overview
        • 10.1.1.7.2 Rest of Europe: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.7.3 Rest of Europe: Aquaculture Vaccines Market, by Type of Vaccine, 2019-2028 (US$ Million)
        • 10.1.1.7.4 Italy: Aquaculture Vaccines Market, by Species, 2019-2028 (US$ Million)
        • 10.1.1.7.5 Rest of Europe: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)

11. Aquaculture Vaccines Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Aquaculture Vaccines Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 HIPRA SA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Merck & Co Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Microsynbiotix Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Zoetis Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Phibro Animal Health Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Elanco Animal Health Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms